Biotec Pharma to Start CGMP Manufacturing for Lead Gene Therapy Products
Biotec Pharma, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, and Biotec Pharma, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that manufacturing operations have commenced to support adeno-associated […]
